These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18510845)

  • 41. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.
    Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B;
    AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Peg-interferon alfa-2a and highly active antiretroviral drug therapy on hepatitis C patients with AIDS].
    Zhang RF; Sun HQ; Huang Q; Wang JR; Zhang XX; Liu XN; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):734-7. PubMed ID: 17963597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
    Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
    J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus co infection in HIV positive patients.
    Balogun TM; Emmanuel S; Wright KO
    Nig Q J Hosp Med; 2010; 20(3):117-20. PubMed ID: 21033318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
    Rauch A; Gaudieri S; Evison J; Nolan D; Cavassini M; Weber R; James I; Furrer H;
    Antivir Ther; 2008; 13(3):455-60. PubMed ID: 18572759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
    Rohrbach J; Robinson N; Harcourt G; Hammond E; Gaudieri S; Gorgievski M; Telenti A; Keiser O; Günthard HF; Hirschel B; Hoffmann M; Bernasconi E; Battegay M; Furrer H; Klenerman P; Rauch A;
    Gut; 2010 Sep; 59(9):1252-8. PubMed ID: 20660698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.
    Kimball P; McDougan F; Stirling R
    Viral Immunol; 2011 Dec; 24(6):441-8. PubMed ID: 22111598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
    Taye S; Lakew M
    BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
    Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
    Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
    J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher dN/dS ratios in the HCV core gene, but not in the E1/HVR1 gene, are associated with human immunodeficiency virus-associated immunosuppression.
    Xu CH; Shen T; Zheng JJ; Tu J; Zhang WD; Lu FM
    Arch Virol; 2012 Nov; 157(11):2153-62. PubMed ID: 22825695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alterations of NK cell frequency and function in HIV/HCV co-infected patients].
    Zhang X; Zhao P; Kang FB; Zhang XW; Si C; Chen XL; Chen WW; Zhao M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):248-50. PubMed ID: 22106474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection.
    Vali B; Yue FY; Jones RB; Sheth PM; Kaul R; Betts MR; Wong D; Kovacs C; Loutfy M; Common A; Halpenny R; Ostrowski MA
    PLoS One; 2008; 3(10):e3454. PubMed ID: 18941622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
    Visseaux B; Larrouy L; Calin R; Katlama C; Poynard T; Ratziu V; Thibault V
    J Clin Virol; 2013 Oct; 58(2):385-90. PubMed ID: 23953940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
    Alidjinou EK; Moukassa D; Ebatetou-Ataboho E; Mahoungou GH; Pambou JP; Sané F; Prevost B; Bocket L; Ibara JR; Hober D
    J Infect Dev Ctries; 2014 Aug; 8(8):1068-71. PubMed ID: 25116677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
    Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.
    Roe B; Coughlan S; Dean J; Lambert JS; Keating S; Norris S; Bergin C; Hall WW
    Viral Immunol; 2009 Feb; 22(1):39-48. PubMed ID: 19210227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
    Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
    J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.